Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1

Completed · Phase 2

Conditions studied: Cocaine-Related Disorders

In brief

The purpose of this study is to evaluate the safety and efficacy of flupenthixol for cocaine dependence in individuals with schizophrenia/schizoaffective illness.

Key facts

Study ID

NCT00000266

Run by

National Institute on Drug Abuse (NIDA)

People needed

0

Starts

1994-08-01

Expected to finish

2001-12-01

Last updated by the study team

2017-01-12

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

• New York State Psychiatric Institute — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.